ASCO 2022

American Society of Clinical Oncology

June 3-7, 2022

This year's meeting will be in-person in Chicago or online attendance.

The American Society of Clinical Oncology (ASCO) annual meeting offers premier scientific events for oncology professionals, patient advocates, industry representatives and major media outlets worldwide.

The 2022 ASCO annual meeting, held in Chicago, provides an opportunity to learn about the latest developments in cancer science from Fred Hutchinson Cancer Center and research institutions around the world. The program features more than 200 sessions complementing the meeting’s theme: Advancing Equitable Cancer Care Through Innovation.

Follow Fred Hutch at ASCO: #ASCO22 |  Facebook  |  Twitter

Date:
Friday-Tuesday, June 03-07, 2022
Host or Sponsor:
American Society of Clinical Oncology
Location:
Chicago, Illinois
Contact Information:
Visit us at the Conference:
Fred Hutch / SCCA Booth: 8024
Fred Hutchinson Cancer Research Center and Seattle Cancer Care Alliance have merged to form Fred Hutchinson Cancer Center, a unified adult cancer research and care center that brings together SCCA and Fred Hutchinson Cancer Research Center into a single, independent, nonprofit organization that is also a clinically integrated part of UW Medicine and UW Medicine’s cancer program. 

Featured Presentations

Joe Unger, Ph.D.

Joe Unger, Ph.D.

Oral Presentation: Impact of broadening trial eligibility criteria on the inclusion of patients with brain metastases in cancer clinical trials 

Monday, June 6, 2:24 p.m. PDT

In 2017, a joint research statement was issued recommending that certain eligibility criteria in cancer clinical trials, including those related to brain metastases, be broadened to make trials more inclusive. Unger and colleagues found that these recommendations were associated with a shift in patterns of brain metastases exclusion criteria from conditionally excluded to not excluded. To the researchers' knowledge, this is the first evidence that cancer clinical trials have become more inclusive of a broader set of patients in response to these recommendations. More inclusive eligibility improves trial access and representativeness, increasing trial validity and the pace at which trials enroll. 
 
Read more about cancer clinical trial inclusion on Hutch News: Cancer clinical trials exclude too many patients: That’s changing

See highlights of presentations from our clinical care team

Highlights of Fred Hutch Presentations at ASCO

Clinical Trials  |  Health Care Systems and Value  |  Cancer Immunology and Immunotherapy  |  Cancer Survivorship  |  Biomarkers

Clinical Trials

Health Care Systems and Value

Cancer Immunology and Immunotherapy

Cancer Survivorship

Biomarkers

Latest ASCO News

All news
ASCO 2022: Equity, innovation and in-person Hutch cancer researchers, clinicians share findings on clinical trial eligibility, Medicaid expansion, wearables to track symptoms and more June 9, 2022
Cancer clinical trials exclude too many patients: That’s changing Calls for equity, inclusion and better access boost pre-pandemic efforts to open up eligibility, streamline trials August 11, 2021

Contact Media Relations

Claire Hudson

Heather Platisha

Last Modified, June 09, 2022